Further falls in CYP3A function may occur with age (Hunt et al, 1990) and reduced hepatic drug clearance may contribute to a greater risk of adverse events in elderly cancer patients (Yancik et al, 1998). The gene discussed is CYP3A4; the disease is cancer.